BioTex - Biohybrid & Medical Textiles

   

The NRW-Schwerpunktprofessur Biohybrids & Medical Textiles, BioTex by short, focuses on the development of viable biohybrid implants with the potential for remodelling, regeneration and self-repair. BioTex wants to make a significant contribution to progress in (regenerative) medicine. We follow the mission to develop bioengineering solutions for clinical needs by combining functional materials and biological components towards biohybrid systems. Therefore, we have set up the institute along the value chain from material development and processing to biohybrid implant development and biofunctionalization and into (pre)clinical testing.

The BioTex institute is in a strong collaboration with the Aachen-Maastricht Institute for Biobased Materials, Director: Prof. Jockenhövel and the DWI Leibniz Institute for Interactive Materials.

In the close collaboration with the DWI, we were able to make a significant contribution to raising the necessary third-party funds for the construction of the Leibniz Joint - Lab first-in-translation (fiT) at the DWI Leibniz Institute. In autumn 2020, construction of the fiT began, which will enable us to produce our current pre-developments under GMP and GLP-compliant conditions and validate them in first clinical trials from 2022 on.